Driven by the booming global health industry and the wave of "Probiotics+" technological innovation, Qingdao Norson Biotechnology Co., Ltd. (a core enterprise of Grand Life Science), a leading pioneer in the bulk probiotic and postbiotic sector, has officially confirmed its participation in CPHI China this June in Shanghai, setting up its specialized technical exhibit at Booth E3A21. Leveraging its robust industrial foundation-which includes a 9,000+ square meter modern manufacturing base, nearly 2,000 square meters of 10,000-class GMP clean workshops, and an annual production capacity of 130+ tons of premium probiotic powder-Norson Bio will unveil comprehensive, turn-key application solutions tailored for functional food, dietary supplements, precision medicine, and more. This move not only showcases the company's hardcore R&D and manufacturing excellence in microecology but also deeply empowers global B2B buyers with premium supply chain solutions.
Powered by our proprietary four-stage strain database and authoritative-certified, localized strains, we deliver top-tier bulk ingredients and comprehensive application solutions across functional food, dietary supplements, precision medicine, and personal care.
During the exhibition, our expert R&D team will be on-site to discuss cutting-edge tech, including food-medicine homologous fermentation processes and direct-to-vat probiotic solutions. We look forward to connecting with global industry peers and strategic partners to unlock new growth together.
📍 Venue: Shanghai New International Expo Centre (SNIEC)
🎪 Norson Bio Booth: E3A21
📅 Date: June 2026
Leave a comment below or send us a message to schedule a one-on-one meeting.
See you in Shanghai!
#CPHIChina 2026
#ProbioticIngredients
#Postbiotics
#BiotechInnovation
#HealthcareIndustry
#NorsonBio